Inventor
Martin Gall
Inventor
Kalamazoo, MI, US
Overview
Patents· 50 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes10%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations9%
H10BElectronic memory devices7%
C07CAcyclic or carbocyclic compounds6%
G11CStatic stores6%
H10DInorganic electric semiconductor devices4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
H10PGeneric processes or apparatus for the manufacture or treatment of devices covered by class h103%
B01DSeparation2%
PatentTitleYear
10,153,062Illumination and imaging device for high-resolution X-ray microscopy with high photon energy201810,151,645Arrangement and method for the synchronous determination of the shear modulus and of the Poisson's number on samples of elastically isotropic and anisotropic materials20187,432,254'Method for treating glaucoma IC'20087,329,330'Method and device for the distillative processing of 1,6-hexanediol, 1,5-pentanediol and caprolactone'20087,166,625'Method for treating fibrotic diseases and other indications'20077,144,570'Sunscreen compositions and methods of use thereof'20067,026,342'Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds'20066,911,732'Integrated circuit'20056,806,268'Method for treating glaucoma V'20046,770,663'Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds'20046,765,302'Semiconductor module having a configurable data width of an output bus, and a housing configuration having a semiconductor module'20046,713,498'Method for treating glaucoma VI'20046,690,612'Voltage supply for semiconductor memory'20046,625,065'Method for masking DQ bits'20036,596,745'Method for treating fibrotic diseases with azolium chroman compounds'20036,596,744'Method for treating fibrotic diseases or other indications IIC'20036,516,537'Method for drying and producing microporous particles'20036,438,867'Method for drying and producing microporous particles and a drying device'20026,383,864'Memory cell for dynamic random access memory (DRAM)'20026,355,954'Device with asymmetrical channel dopant profile'20026,320,803'Method and apparatus for improving the testing, yield and performance of very large scale integrated circuits'20016,288,286'Method for producing hexanediol-1,6'20016,090,671'Reduction of gate-induced drain leakage in semiconductor devices'20006,078,534'Semiconductor memory having redundancy circuit'20006,025,224'Device with asymmetrical channel dopant profile'20006,004,844'Unit cell layout and transfer gate design for high density DRAMs'19995,936,271'Unit cell layout and transfer gate design for high density DRAMs having a trench capacitor with signal electrode composed of three differently doped polysilicon layers'19995,262,537'Derivatives of 4,5,6,7-tetrahydroimidazo-[4,5-c]pyridinyl-6-carboxylic acid'19934,996,318'Amino-9,10-secosteroids useful for treating head injury, spinal cord trauma or stroke'19914,577,020'Aminoalkyl and aminoalkenyl triazoles as anti-psychotic agents'19864,481,360'4H-1,2,4-Triazol-3-yl compounds'19844,474,699'Preparing 1-aminomethyl-6-substituted-4H-s-triazolo[4,3-a][1,4]benzodiazepines in improved procedures'19844,408,049'Substituted piperazinyl-1,2,4-triazoles'19834,404,382'Piperazinyl-substituted imidazoles'19834,404,387'Aminoalkyl-substituted imidazoles'19834,338,453'Aminoalkyl-1,2,4-triazoles'19824,020,085'1-(.alpha.-Amino-.alpha.-phenyl-o-tolyl)imidazoles'19774,010,177'[3-Substituted-5-[(di-methylamino)methyl]-4H-1,2,4-triazol- 4-yl]benzophenones and process'19774,005,099'1-[(Dimethylamino)-methyl]-6-aryl-4H-imidazo[1,5-a][1,4]benzodiazepines'19774,001,262'Process for the production of 1-[(dimethylamino)methyl]-6-phenyl-4H-triazolo[4,3-a][1,4]-benzodiazepin e'19774,001,261'Process for the production of 1-[(dimethylamino)methyl]-6-phenyl-4H-imidazo[1,2-a][1,4]-benzodiazepine'19773,992,408'Phthalimido alkanone, ethylene ketals'19763,992,393'Novel imidazobenzodiazepine derivative'19763,992,400'1-(.alpha.-Phenyl-o-tolyl)imidazoles'19763,970,666'3,5-Disubstituted-4-(.alpha.-amino-.alpha.-phenyl-o-tolyl)-4H-1,2,4-triaz oles'19763,957,761'Process for the production of 1-aminomethyl-6-phenyl-4h-s-triazolo-[4,3-a][ 1 ]benzodiazepines and intermediates'19763,956,297'9H-Dibenzo[b,f]imidazo[1,2-d][1,4]diazepines'19763,947,466'Intermediates and process for the production of certain triazolobenzodiazepines'19763,941,803'2-(Imidazol-1-yl)benzophenones'19763,941,802'2-(Imidazol-1-yl)benzophenones'1976Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1976–1991Patents assigned to UPJOHN CO (22)· patent assignee history
1976–1991Based in Kalamazoo, MI, US· patent location history
1999–2002Patents assigned to SIEMENS AG (7)· patent assignee history
2000–2002Based in South Burlington, VT, US· patent location history
2001–2008Patents assigned to BASF AG (4)· patent assignee history
2001–2008Based in Mutterstadt, DE· patent location history
2003–2007Patents assigned to ALTEON INC (8)· patent assignee history
2003–2005Patents assigned to INFINEON TECHNOLOGIES AG (4)· patent assignee history
2003–2008Based in Morristown, NJ, US· patent location history
2003–2004Based in Mnchen, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UPJOHN CO | 22 | 1976–1991 |
| ALTEON INC | 8 | 2003–2007 |
| SIEMENS AG | 7 | 1999–2002 |
| BASF AG | 4 | 2001–2008 |
| INFINEON TECHNOLOGIES AG | 4 | 2003–2005 |
Locations
| Location | Patents | Span |
|---|---|---|
| Kalamazoo, MI, US | 22 | 1976–1991 |
| Morristown, New Jersey, US | 9 | 2003–2008 |
| Mutterstadt, DE | 4 | 2001–2008 |
| Mnchen, DE | 3 | 2003–2004 |
| South Burlington, VT, US | 3 | 2000–2002 |